Blocking pro-fibrosis pathway may improve immunotherapy of metastatic breast cancer
Drug approved for lymphoma and multiple myeloma may reduce fibrosis and immunosuppression A Massachusetts General Hospital (MGH) research team has found that the overgrowth of...








